Focus of attention will once again be on the US docket
“Upcoming data is expected to shed extra details on the US recovery, with yields and price action in the dollar closely following. In the US docket, US Retail Sales will be in the limelight seconded by Industrial Production figures and the flash prints of the U-Mich index.”
“The continuation of the downtrend is seen meeting interim contention at the 50-day SMA just above 109.00. This area of contention is also reinforced by the Fibo level (of the 2021 rally) around 109.00. Further south comes in the monthly lows around 108.30 (May 7/11).”
“On the upside, the surpass of monthly tops around 109.80 should open in the door to the key level at 110.00 the figure ahead of the YTD highs in levels just shy of 111.00 (March 31).”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.